COMMENT

Two completely different horses. Amazon is more innovative so it could have higher growth, but Microsoft has new upgrades, new contracts and is more stable. He wouldn't own either because FANGS make up about 20% of the index funds, so they will go down more than the others. Would buy half a position and add more depending. On a risk basis, it's too exposed to the overall market.

BUY

The stock has been flat. A conglomerate across SE Asia. It's a big conglomerate which includes BMW/ Mercedes dealerships, financials, hotels, supermarkets, parts of Ikea and Starbucks franchises. They are also sitting on a ton of cash. Likes this company because they make smart acquisitions.

BUY
An income generator. More than 60% of income comes from emerging markets. They are making acquisitions in the millennial segment and they will continue to perform well.
BUY
They manage 2400 pawn shops, with many in Mexico. It's also a hedge for gold since they trade gold jewelry. Almost two times cashflow then owning most of the companies out there. It will continue to do well.
BUY ON WEAKNESS

He's not worried because retail is still TD's main business. The discount brokers was to bring trading cost to 0. It's all noise and this is where people get emotional and start selling. He would jump in right now.

BUY
Essentially a water sterilization company for hospitals and dental offices. Their latest acquisition was to double down in dental. Right now, it's in the $69 and value is there. It's grown dividends by 20% per year.
PAST TOP PICK
(A Top Pick Oct 12/18, Up 2%) They have come back to levels before the China war. China is only 1/3 of the business' revenue. They also have business in India and US for water purification, heating, and others. This company continues to be working in the water purification sector. They raised dividends by 9%. This will depend on how the US-China trade war wraps up.
PAST TOP PICK
(A Top Pick Oct 12/18, Up 25%) They've been able to raise prices in the last year. They are a high quality re-insurer. The opioid crisis is the only concern. It's still a buy and he continues to buy it.
PAST TOP PICK
(A Top Pick Oct 12/18, Up 34%) Profits from aging population. They have sterile equipment. It will continue to do well. Medical sectors as a whole had a great year.
DON'T BUY
Despite the fact that numbers may look good, the ethics of the firm and future liabilities of congress hearing is a risk. He would avoid it right now.
DON'T BUY
An ethical issue with all the anti-money laundering issues in Russian and eastern European countries. They aren't growing revenues to offset costs. There are other European banks that are clean with a much higher rate. There are also negative interest rates in Europe right now so it's difficult for them to grow business.
COMMENT
The dividend hasn't risen that much. They've made progress in their offshore wind project, as well as a project in Mexico. Their Q2 results were the same as results from a year ago. They need to keep growing to pay down debt and pay dividends.
BUY ON WEAKNESS
The U.S. banks have had a big rally with the Fed's cutting interest rates. They are a bit pricy right now. They've been buying back shares and they have had little growth.
BUY
An Indian bank tied into the Indian government. They carry a AAA rate. They are trading flat this year. They have held up well compared to others in the field.
COMMENT
In the last quarter, their revenues were up 1% but missed their earnings by 20%. When you are in the manufacturing sector, it's a capital intensive business. Then, you have to continue to borrow or continue to grow. Their acquisition hasn't been the best.